About 1 in 3 adults in the United States have prediabetes, a condition where blood glucose levels are higher than normal, but not high enough to be diagnosed as diabetes.

Icovamenib met the primary endpoint, displaying a meaningful statistically significant placebo-corrected mean reduction in HbA1c in the ...

A more precise risk calculation also benefits diabetes screening programs that have become more common in the United States and around the world. Jacobsen, the lead author in the “personal views ...

Researchers found a 3% lower risk of Type 2 diabetes for each additional weekly ... than 190,000 health care professionals in the United States for over 30 years. Instead, the study showed ...

Health knowledge about sugar-sweetened beverages (SSBs) does not significantly reduce high SSB consumption, which is driven ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

Cal Poly has received a $10.6 million grant from the nonprofit Patient-Centered Outcomes Research Institute (PCORI) ...

While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials ...

As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented ...